Monoclonal Antibody Diagnostic Reagents Market, By Diagnostic Tests (Double Antigen Sandwich Chemiluminescence Method, Dot-immunogold Filtration Assay, and Recombinant Immunoblot Assay, Enzyme Linked Immunosorbent Assay), By Application (Tumor Monitoring, Hormones Diagnosis, Virus Detection, and Others) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) - Trends, Analysis and Forecast till 2034

Report Code: PMI5318 | Publish Date: February 2024 | No. of Pages: 180

Global Monoclonal Antibody Diagnostic Reagents Overview

Introduction:

Monoclonal Antibody Diagnostic Reagents Market was valued at US$ 8.5 billion in 2024 and is projected to grow at a CAGR of 12.3% to reach US$ 27.2 billion by 2034.

Antibodies are an essential tool for many applications including flow cytometric analysis, immunoprecipitation, enzyme-linked immunosorbent assay (ELISA), immunocytochemistry, western blotting, and immunohistochemistry. Moreover, monoclonal antibodies (MAbs) are significant diagnostic reagent used in microbiological research, biomedical research, and also in diagnosis of various diseases such as HIV, hepatitis, herpes simplex, influenza infections, chlamydia, as well as for the treatment of cancer. Therefore, due to its importance in the clinical application, it is expected to boost the Monoclonal Antibody Diagnostic Reagents Market growth during the forecast period.

Monoclonal antibodies diagnostic reagent is routinely used in radioimmunoassay and enzyme-linked immunosorbent assays in laboratories. Further, these assays measure the circulating concentration of hormones and cell products. Thus, owing to its broad application, the Monoclonal Antibody Diagnostic Reagents Market will gain more share value in the coming years.

Monoclonal Antibody Diagnostic Reagents Market - Introduction

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Global Monoclonal Antibody Diagnostic Reagents Dynamics

Presently, the rising prevalence of diseases and infections is a major driving factor driving the global market. Additionally, increasing research & developmental activity in the diagnostic field is likely to act as a growth engine for the global market.

However, high cost and need of considerable time may hinder the monoclonal antibody diagnostic reagents market growth within the forecast period.

Global Monoclonal Antibody Diagnostic Reagents Segmentation

Monoclonal Antibody Diagnostic Reagents Market is segmented on the basis of Diagnostic tests, Application, and Region.

The diagnostic test type segment includes a double antigen sandwich chemiluminescence method, dot-immunogold filtration assay, and recombinant immunoblot assay, enzyme-linked immunosorbent assay.

On the basis of application, the monoclonal antibody diagnostic reagents market is segmented into tumor monitoring, hormones diagnosis, virus detection, and others.

Regional Insights:

Monoclonal Antibody Diagnostic Reagents Market - Regional Insights

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

On the basis of region, the target market has been segmented into North America, Latin America, Asia Pacific, Europe, Middle East and Africa. North America is expected to account major market share as compared to that of other regions.

Report Scope:

Attribute

Details

Market Size 2024

US$ 8.5 billion

Projected Market Size 2034

US$ 27.2 billion

CAGR Growth Rate

12.30%

Base year for estimation

2023

Forecast period

2024 – 2034

Market representation

Revenue in USD Billion & CAGR from 2024 to 2034

Market Segmentation

By Diagnostic Tests - Double Antigen Sandwich Chemiluminescence Method, Dot-immunogold Filtration Assay, and Recombinant Immunoblot Assay, Enzyme Linked Immunosorbent Assay

By Application - Tumor Monitoring, Hormones Diagnosis, Virus Detection, and Others

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study, has segmented the Monoclonal Antibody Diagnostic Reagents Market report based on diagnostic tests, application, and region.:

Monoclonal Antibody Diagnostic Reagents Market , By Diagnostic Tests:

  • Double Antigen Sandwich Chemiluminescence Method
  • Dot-immunogold Filtration Assay
  • Recombinant Immunoblot Assay
  • Enzyme Linked Immunosorbent Assay

Monoclonal Antibody Diagnostic Reagents Market , By Application:

  • Tumor Monitoring
  • Hormones Diagnosis
  • Virus Detection
  • Others

Monoclonal Antibody Diagnostic Reagents Market , By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • Israel
    • South Africa
    • Rest of Middle East & Africa

Global Monoclonal Antibody Diagnostic Reagents Key Players

The key players operating the Monoclonal Antibody Diagnostic Reagents Market includes AnaSpec, Bio-Rad, BioGenex, BioVision,  Biocare Medical, Creative Diagnostics, GenWay Biotech, Celltrion, MedixBiochemica, Innovent Biologics, Qiagen, and Teva Pharmaceutical Ltd.

Global Monoclonal Antibody Diagnostic Reagents Company Profile

  • Bio-Rad*
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • AnaSpec
  • BioGenex
  • BioVision
  • Biocare Medical
  • Creative Diagnostics
  • GenWay Biotech
  • Celltrion
  • MedixBiochemica
  • Innovent Biologics
  • Qiagen
  • Teva Pharmaceutical Ltd.

“*” marked represents similar segmentation in other categories in the respective section.

Global Monoclonal Antibody Diagnostic Reagents Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for medical carts Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Diagnostic Tests
      • Market Snippet, By Application
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restrains
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5.  Monoclonal Antibody Diagnostic Reagents Market, By Diagnostic Tests, Forecast Period up to 10 Years, (US$ Bn)
  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Double Antigen Sandwich Chemilumunescence Menthod
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Dot-immunogold Filtration Assay
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Recombinant Immunoblot Assay
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Enzyme Linkend Immunosorbent
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  1.  Monoclonal Antibody Diagnostic Reagents Market, By Application, Forecast Period up to 10 Years, (US$ Bn)
  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Tumor Monitoring
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Hormones Diagnosis
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Virus
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Others
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  1.  Monoclonal Antibody Diagnostic Reagents Market, By Region, Forecast Period up to 10 Years, (US$ Bn)
    • Overview
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
      • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Bn), By Diagnostic Tests, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Bn), By Diagnostic Tests, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
        • UK
        • France
        • Germany
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Bn), By Diagnostic Tests, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
        • India
        • Japan
        • South Korea
        • China
        • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast (US$ Bn), By Diagnostic Tests, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
    • Market Size and Forecast (US$ Bn), By Diagnostic Tests, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East
  1. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  2. Company Profiles
  • AnaSpec
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Bio-Rad
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • BioGenex
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • BioVision
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Biocare Medical
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Creative Diagnostics
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • GenWay Biotech
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Celltrion
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • MedixBiochemica
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Innovent Biologics
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  1. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

The global monoclonal antibody diagnostic reagents market is segmented on the basis of diagnostic tests, application, and region.

The rising prevalence of diseases and infections is a major driving factor driving the global market.

North America is expected to account major market share as compared to that of other regions.

The key players operating in the global market of the monoclonal antibody diagnostic reagents include AnaSpec, Bio-Rad, BioGenex, BioVision, Biocare Medical, Creative Diagnostics, GenWay Biotech, Celltrion, MedixBiochemica, Innovent Biologics, Qiagen, and Teva Pharmaceutical Ltd.

High cost and need of considerable time may hinder the global monoclonal antibody diagnostic reagents market growth within the forecast period.